- Symptoms of severe AS = angina, syncope, dyspnea/HF (or lower exercise tolerance). Once symptoms start, survival drops fast without valve replacement.
- Severe AS: Vmax ≥4 m/s, mean gradient ≥40 mmHg, AVA ≤1.0 cm² (AVAi ≤0.6). Discordant numbers → low-flow work-up.
- Symptomatic severe AS → AVR (TAVR or SAVR) — Class 1 in all guidelines. Heart Team decides the route.
- Ward rules — "fixed door": keep preload (gentle diuresis), keep HR slow and sinus rhythm, avoid big vasodilator drops; hypotension → phenylephrine or norepinephrine.
- Decompensated and too sick for AVR → balloon aortic valvuloplasty as a bridge.
- GI bleeding from angiodysplasia + AS = Heyde syndrome → AVR often stops it.
Pathophysiology in 60 seconds
⌄
A calcified valve is a fixed, narrow door. The LV must push much harder (the shaded gap is the gradient). Cardiac output cannot rise much — so anything that drops filling or BP can cause collapse.
- Calcified (age, bicuspid valve) or rheumatic leaflets → fixed obstruction to outflow.
- LV adapts with concentric hypertrophy → stiff, preload-dependent ventricle that needs the atrial kick.
- Angina: thick muscle needs more O₂, while high LV pressure squeezes the coronaries and diastole is short.
- Syncope: on exertion, muscles vasodilate but cardiac output cannot rise through the narrow valve → BP falls.
- HF: high filling pressures (diastolic dysfunction), later the LV fails (low EF).
Diagnosis
⌄
Exam: harsh crescendo–decrescendo systolic murmur at the right upper sternal border → carotids · later peak = more severe · soft or absent S2 · pulsus parvus et tardus (weak, late carotid upstroke) · S4.
| Stage | Vmax | Mean gradient | AVA |
|---|---|---|---|
| Mild | 2.0–2.9 m/s | <20 mmHg | >1.5 cm² |
| Moderate | 3.0–3.9 m/s | 20–39 mmHg | 1.0–1.5 cm² |
| Severe | ≥4.0 m/s | ≥40 mmHg | ≤1.0 cm² |
| Very severe | ≥5.0 m/s | ≥60 mmHg | — |
AVA ≤1.0 cm² but gradient <40 mmHg. Is the valve really tight, or is the LV too weak to open it?
| Type | Next test |
|---|---|
| Low EF (<50%) — "classical" | Low-dose dobutamine echo: gradient rises ≥40 with AVA staying ≤1.0 → true severe AS. AVA opens up → pseudo-severe |
| Normal EF, SVi <35 mL/m² — "paradoxical" (small, thick LV; often HTN, women, AF) | CT aortic valve calcium score: severe likely ≥2000 AU men / ≥1200 AU women; very likely ≥3000 / ≥1600 |
- HCM (LVOT obstruction): murmur louder with Valsalva/standing, softer with squatting; normal carotid upstroke (brisk, bifid).
- Aortic sclerosis: murmur without gradient (Vmax <2.5 m/s).
- Mitral regurgitation: holosystolic at the apex → axilla.
- Subvalvular/supravalvular stenosis (young patients) → echo.
Workup
⌄
- TTE (severity, EF, other valves). Repeat if symptoms change.
- ECG (LVH, AF, conduction disease), BNP (prognosis), CBC (Heyde).
- Cardiac CT (TAVR protocol) and coronary evaluation (cath or CT) before AVR.
- Exercise testing only in truly asymptomatic patients — never in symptomatic severe AS.
- Consider ATTR cardiac amyloid in older patients with low-flow AS (common overlap) → PYP scan + light chains.
Management
⌄
| Problem | Do | Avoid |
|---|---|---|
| Volume overload | Gentle loop diuretic, daily weights | Over-diuresis → preload crash |
| Hypotension / sepsis | Fluids in small boluses + phenylephrine or norepinephrine | Dobutamine/milrinone alone (vasodilate) — unless low-EF AS under expert care |
| AF with RVR | Early cardioversion if unstable; rate control carefully | Large IV diltiazem pushes in a hypotensive patient |
| Hypertension | Start low, go slow (ACEi/ARB OK) | Big drops with nitro/hydralazine drips |
| Sedation / intubation | Etomidate or small doses, pressor ready | Large propofol bolus |
| Neuraxial anesthesia | Discuss with anesthesia | Rapid sympathectomy |
- AVR indicated (Class 1): symptomatic severe AS · asymptomatic severe AS with EF <50% · severe AS having other cardiac surgery.
- Reasonable: very severe AS (Vmax ≥5), abnormal exercise test, rapid progression, high BNP — in low-risk patients.
- TAVR vs SAVR (Heart Team + shared decision):
- ACC/AHA 2020: >80 y → TAVR, 65–80 → either, <65 → SAVR (anatomy, life expectancy, bicuspid valve matter).
- ESC/EACTS 2025: TAVI for age ≥70 with a tricuspid valve and suitable anatomy, whatever the surgical risk.
- Balloon valvuloplasty: bridge in shock or before urgent noncardiac surgery.
- Palliative care when AVR is not in the patient's goals or life expectancy is <1 year.
- EARLY TAVR (2024): early TAVR vs surveillance in asymptomatic severe AS → fewer deaths, strokes or unplanned CV hospitalizations (driven by hospitalizations); many in the surveillance arm needed AVR within ~2 years.
- ESC/EACTS 2025 now supports early intervention in selected asymptomatic patients with severe high-gradient AS and normal EF if procedural risk is low.
- US: the 2020 ACC/AHA guideline predates EARLY TAVR. CMS (2026) still covers TAVR for asymptomatic AS only within approved studies. Expect change — check for a US update.
- Either way: ask about symptoms carefully — many "asymptomatic" patients have quietly slowed down.
- Symptomatic severe AS + elective surgery → AVR (often TAVR) first.
- Asymptomatic severe AS → elevated-risk elective surgery is reasonable with invasive monitoring, careful volume, avoid tachycardia and hypotension.
- Urgent surgery → proceed with anesthesia/cardiology plan; BAV in selected cases.
No drug slows AS. Statins did not work (SEAS, ASTRONOMER, SALTIRE) — treat lipids for atherosclerosis, not for the valve.
Pitfalls
⌄
- Calling it "flow murmur" in an older patient with syncope.
- Aggressive diuresis or nitro drip → sudden hypotension and arrest.
- Missing low-flow, low-gradient severe AS because "the gradient is only 30."
- Treating GI bleeding again and again without thinking of Heyde syndrome.
- Missing ATTR amyloid alongside AS in elderly patients.
Board corner
⌄
| Stem | Answer |
|---|---|
| 78-year-old, exertional syncope, late-peaking murmur, soft S2 | Severe AS → TTE → AVR |
| Severe AS, EF 25%, gradient 25, AVA 0.8 | Low-flow AS → dobutamine echo |
| Murmur louder with Valsalva, quieter with squatting | HCM (not AS) |
| AS + recurrent GI bleeding from angiodysplasia | Heyde syndrome (acquired vWF deficiency) → AVR |
| Severe AS patient becomes hypotensive after sedation | Phenylephrine / norepinephrine |
| 84-year-old with symptomatic severe AS, suitable anatomy | TAVR |
| 55-year-old, bicuspid valve, symptomatic severe AS, low risk | SAVR |
References
⌄
- Otto CM, et al. 2020 ACC/AHA guideline for the management of valvular heart disease. Circulation. 2021;143:e72.
- Praz F, et al. 2025 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2025. doi:10.1093/eurheartj/ehaf194.
- Généreux P, et al. TAVR for asymptomatic severe aortic stenosis (EARLY TAVR). N Engl J Med. 2025;392:217.
- Thompson A, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM guideline for perioperative cardiovascular management for noncardiac surgery. Circulation. 2024;150:e351.
- CMS. TAVR National Coverage Determination, 2026 update.
- MGH White Book 2019–2020: Valvular heart disease (structure).